BD® Surgiphor™ Antimicrobial Irrigation System
The OR is no place for compromise. Make Surgiphor™ Irrigation System your standard of care.
- Overview
- Products & Accessories
- EIFU & Resources
Control what you can in the OR with
surgical wound irrigation
The Operating Room is a dynamic environment where every second matters. Your choice of wound irrigation can make a difference for surgeries. The Surgiphor™ Antimicrobial Irrigation System is the only ready-to-use, terminally sterile, surgical irrigation solution cleared by the FDA1 to deliver a dilute povidone-iodine (PVP-I) lavage.*†
Surgiphor™ Antimicrobial Irrigation System is terminally sterile, minimizing the risk of contamination and aligning with USP <797> standards to ensure a sterile solution for every operation.2 Designed to reduce variability in process, it promotes best practices in surgical irrigation through consistent concentration. The pre-mixed, pre-labeled system saves valuable OR time, requires no special training, and provides a 99.99% antimicrobial reduction with PVP-I preservative in the solution.‡3
We needed a product that was
ready-to-use and sterile.
One trusted solution. Two ways to deliver.
The only portfolio to offer terminally sterile povidone-iodine (PVP-I) solution in multiple sizes and delivery options designed to meet your surgical irrigation needs.
BD® Surgiphor™ 450mL
Compressible bottle designed for manual irrigation delivery.
BD® Surgiphor™ 1000mL
Flexible bottle system with adaptor and
Y-connector for powered irrigation delivery—
also compatible with manual use.
BD® Surgiphor™ 450 ML
Compact, compressible, ready-to-use
The Surgiphor™ Antimicrobial Irrigation System is a 450 mL bottle designed with multiple innovations to help you make sterility standard.
Click on each hot spot to see how it can enable you to improve control, confidence and quality assurance in the OR.
BD® Surgiphor™ 1000 ML
Manual or powered irrigation flexibility
Ideal for higher-volume procedures or cases using pulse lavage and other powered devices, the Surgiphor™ 1000 mL Irrigation System includes everything needed for manual or powered delivery—all in one sterile, ready-to-use package.
Click on each hot spot to see how it provides flexible irrigation delivery.
4 Reasons to select Surgiphor™ Antimicrobial Irrigation System
- US Food and Drug Administration. 2022 K221504 Trade/Device Name: BD Surgiphor Antimicrobial Irrigation System. https://www.accessdata.fda.gov/cdrh_docs/pdf22/ K221504.pdf. Accessed April 5, 2025.
- United States Pharmacopeia (USP) <797>, Immediate-use CSPs. Rockville, MD; 2022.
- Surgiphor Solution Preservative Effectiveness Report. Orthopor LLC; 2019.
- National Patient Safety Goals® Effective January 2023 for the Hospital Program. The Joint Commission website. http://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-safety-goals/2023/npsg_chapter_hap_jan2023.pdf. Published January 2023.
- Surgiphor Gamma Sterilization Validation Test Report. Orthopor LLC; 2019.
- Association for the Advancement of Medical Instrumentation (AAMI). ANSI/AAMI ST67:2019. Sterilization of health care products—Requirements and guidance for selecting a sterility assurance level (SAL) for products labeled “sterile”. Arlington: AAMI; 2019.
- Gabriel A, Schraga ED, Windle ML. Wound irrigation: Overview, preparation, technique. Medscape. https://emedicine.medscape.com/article/1895071-overview. Updated August 26, 2021. Accessed January 12, 2026.
- BD Surgiphor 1000mL Instructions for Use.
- AORN (2023), Guideline Quick View: Medication Safety. AORN J, 117: 414-418. https://doi.org/10.1002/aorn.13951
- Surgiphor System Mechanical Action Report. Orthopor LLC; 2019.
- Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 [published correction appears in JAMA Surg. 2017;152(8):803]. JAMA Surg. 2017;152(8):784-791.
- World Health Organization. Global guidelines for the prevention of surgical site infections. https://www.who.int/publications/i/item/ 9789241550475.
- Calderwood MS, Anderson DJ, Bratzler DW, et al. Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023;44(5):695-720.
* Indication for use: BD Surgiphor™ Antimicrobial Irrigation System is intended to mechanically loosen and remove debris and foreign materials, including microorganisms, from wounds.
† PVP-I is an antimicrobial preservative contained within the bottled solution. The BD Surgiphor™ solution is not indicated for use as an antimicrobial at or within the wound site.
‡ At initial time point of 7 days. Product should be used only within 24 hours of opening per IFU.
Surgiphor™ Antimicrobial Irrigation System
Product description. Surgiphor™ Antimicrobial Irrigation System is an antimicrobial irrigation system containing 0.5% povidone iodine (PVP-I) in phosphate-buffered saline, potassium iodide and Vitamin E TPGS. PVP-I acts as a preservative to help inhibit microbial growth in the irrigation solution. Indication for use. Surgiphor™ Antimicrobial Irrigation System is intended to mechanically loosen and remove debris, and foreign materials, including microorganisms, from wounds. Contraindications. Surgiphor™ Antimicrobial Irrigation System should not be used in patients with known allergic reaction to any of the ingredients in the solutions. Surgiphor™ Antimicrobial Irrigation System should also not be combined with other irrigation or antiseptic solutions due to potential reactions and reduction in the effectiveness of the system. Not for use in neonates. Warnings. Do not use or mix with other cleansers, soaps, lotions, or ointments. Do not use for injection or infusion. Do not swallow. Do not use in eyes or ear canals. Discontinue use immediately if irritation or an allergic reaction occurs. Do not use if packaging is damaged or if seal integrity is compromised. Do not reuse Surgiphor™ solution after 24 hours. Precautions. Surgiphor™ solution may cause a temporary irritation and/or burning sensation on exposed skin in very rare cases. Surgiphor™ solution may cause allergic reactions such as rash or skin irritation in patients with iodine allergy. Anaphylaxis with the use of Surgiphor™ solution may occur in patients with severe iodine allergy. Federal law restricts this device to sale by or on the order of a licensed physician. Single patient use only. Not for at-home use.
Please consult product insert for complete indications, contraindications, warnings, precautions, safety information and instructions for use.
-
The BD Ambulatory Surgery Center portfolio of category-leading products, innovative solutions and dedicated support is designed to help ASCs improve clinical efficiency and enhance patient care.
-
We offer a full portfolio of surgical products
AAOS: American Academy of Orthopaedic Surgeons; CDC: Centers for Disease Control and Prevention; USP: United States Pharmacopeial Convention; WHO: World Health Organization
**PVP-I is an antimicrobial preservative contained within the bottled solution. The Surgiphor solution is not indicated for use as an antimicrobial at or within the wound site.
†Sterility assurance level in accordance with ISO 11137. *At initial time point of 7 days. Product should be used only within 24 hours of opening per IFU. ^Preservative solution with 0.5% PVP-I tested against Candida albicans (ATCC #10231), Pseudomonas aeruginosa (ATCC #9027), Aspergillus brasiliensis (ATCC #16404), Escherichia coli (ATCC #8739) and Staphylococcus aureus (ATCC #6538). **Against USP <51> organisms for up to 28 days.8 Once opened, the product should not be used on the patient after 24 hours. #Shown by the in-vitro antimicrobial efficacy of the PVP-I preservative in the BD Surgiphor™ solution.
Indication for use: Surgiphor™ Antimicrobial Irrigation System is intended to mechanically loosen and remove debris, and foreign materials, including microorganisms, from wounds. Contraindications: Surgiphor™ Antimicrobial Irrigation System should not be used in patients with known allergic reaction to any of the ingredients in the solutions. Surgiphor™ Antimicrobial Irrigation System should also not be combined with other irrigation or antiseptic solutions due to potential reactions and reduction in the effectiveness of the system. Not for use in neonates. Warnings: Do not use or mix with other cleansers, soaps, lotions, or ointments. Do not use for injection or infusion. Do not swallow. Do not use in eyes or ear canals. Discontinue use immediately if irritation or an allergic reaction occurs. Do not use if packaging is damaged or if seal integrity is compromised. Do not reuse Surgiphor™ solution after 24 hours. Precautions: Surgiphor™ solution may cause a temporary irritation and/or burning sensation on exposed skin in very rare cases. Surgiphor™ solution may cause allergic reactions such as rash or skin irritation in patients with iodine allergy. Anaphylaxis with the use of Surgiphor™ solution may occur in patients with severe iodine allergy. Federal law restricts this device to sale by or on the order of a licensed physician. Single patient use only. Not for at-home use. Please consult product insert for complete indications, contraindications, warnings, precautions, safety information and instructions for use.
References:
- Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection. JAMA Surg. 2017;152(8):784-791. doi: 10.1001/jamasurg.2017.0904
- World Health Organization (WHO). Global Guidelines for the Prevention of Surgical Site Infection, 2nd edition. Geneva: World Health Organization; 2018. Accessed on September 6, 2022, at https://apps.who.int/iris/rest/bitstreams/1168437/retrieve.
- American Academy of Orthopaedic Surgeons (AAOS). Intraoperative Risk Factors. In Surgical Risk Reduction Toolkit. Accessed on September 6, 2022, at https://www.aaos.org/quality/quality-programs/quality-toolkits/prevention-of-surgical-site-infection/.
- Surgiphor Gamma Sterilization Validation Test Report. Orthopor LLC; 2019.
- Association for the Advancement of Medical Instrumentation (AAMI). ANSI/AAMI ST67:2019. Sterilization of health care products—Requirements and guidance for selecting a sterility assurance level (SAL) for products labeled “sterile”. Arlington: AAMI; 2019.
- 3National Patient Safety Goals® Effective January 2023 for the Hospital Program. The Joint Commission website. http://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-safety-goals/2023/npsg_chapter_hap_jan2023.pdf. Published January 2023. Accessed January 26, 2023.
- Surgiphor System Mechanical Action Report. Orthopor LLC; 2019.
- Surgiphor Solution Preservative Effectiveness Report. Orthopor LLC; 2019.
Our collection of literature on industries and on our offerings gives you information you can use to continue striving for excellence.
We support the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
The BD Learning Academy offers a centralized repository of BD product training, education, and the ability to connect courses to your LMS.
We promote clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
AAOS: American Academy of Orthopaedic Surgeons; CDC: Centers for Disease Control and Prevention; USP: United States Pharmacopeial Convention; WHO: World Health Organization
**PVP-I is an antimicrobial preservative contained within the bottled solution. The Surgiphor solution is not indicated for use as an antimicrobial at or within the wound site.
†Sterility assurance level in accordance with ISO 11137. *At initial time point of 7 days. Product should be used only within 24 hours of opening per IFU. ^Preservative solution with 0.5% PVP-I tested against Candida albicans (ATCC #10231), Pseudomonas aeruginosa (ATCC #9027), Aspergillus brasiliensis (ATCC #16404), Escherichia coli (ATCC #8739) and Staphylococcus aureus (ATCC #6538). **Against USP <51> organisms for up to 28 days.8 Once opened, the product should not be used on the patient after 24 hours. #Shown by the in-vitro antimicrobial efficacy of the PVP-I preservative in the BD Surgiphor™ solution.
Indication for use: Surgiphor™ Antimicrobial Irrigation System is intended to mechanically loosen and remove debris, and foreign materials, including microorganisms, from wounds. Contraindications: Surgiphor™ Antimicrobial Irrigation System should not be used in patients with known allergic reaction to any of the ingredients in the solutions. Surgiphor™ Antimicrobial Irrigation System should also not be combined with other irrigation or antiseptic solutions due to potential reactions and reduction in the effectiveness of the system. Not for use in neonates. Warnings: Do not use or mix with other cleansers, soaps, lotions, or ointments. Do not use for injection or infusion. Do not swallow. Do not use in eyes or ear canals. Discontinue use immediately if irritation or an allergic reaction occurs. Do not use if packaging is damaged or if seal integrity is compromised. Do not reuse Surgiphor™ solution after 24 hours. Precautions: Surgiphor™ solution may cause a temporary irritation and/or burning sensation on exposed skin in very rare cases. Surgiphor™ solution may cause allergic reactions such as rash or skin irritation in patients with iodine allergy. Anaphylaxis with the use of Surgiphor™ solution may occur in patients with severe iodine allergy. Federal law restricts this device to sale by or on the order of a licensed physician. Single patient use only. Not for at-home use. Please consult product insert for complete indications, contraindications, warnings, precautions, safety information and instructions for use.
References:
- Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection. JAMA Surg. 2017;152(8):784-791. doi: 10.1001/jamasurg.2017.0904
- World Health Organization (WHO). Global Guidelines for the Prevention of Surgical Site Infection, 2nd edition. Geneva: World Health Organization; 2018. Accessed on September 6, 2022, at https://apps.who.int/iris/rest/bitstreams/1168437/retrieve.
- American Academy of Orthopaedic Surgeons (AAOS). Intraoperative Risk Factors. In Surgical Risk Reduction Toolkit. Accessed on September 6, 2022, at https://www.aaos.org/quality/quality-programs/quality-toolkits/prevention-of-surgical-site-infection/.
- Surgiphor Gamma Sterilization Validation Test Report. Orthopor LLC; 2019.
- Association for the Advancement of Medical Instrumentation (AAMI). ANSI/AAMI ST67:2019. Sterilization of health care products—Requirements and guidance for selecting a sterility assurance level (SAL) for products labeled “sterile”. Arlington: AAMI; 2019.
- 3National Patient Safety Goals® Effective January 2023 for the Hospital Program. The Joint Commission website. http://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-safety-goals/2023/npsg_chapter_hap_jan2023.pdf. Published January 2023. Accessed January 26, 2023.
- Surgiphor System Mechanical Action Report. Orthopor LLC; 2019.
- Surgiphor Solution Preservative Effectiveness Report. Orthopor LLC; 2019.